GI
NGM

GAMMA Investing’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

GAMMA Investing’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-346
Closed -$550 – 3546
2024
Q1 		$550 Hold
346
– – ﹤0.01% 3090
2023
Q4 		$529 Buy
+346
New +$304 ﹤0.01% 2956

GAMMA Investing's NGM Position: Q2 2024 in Review

GAMMA Investing sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 346 shares — an estimated $550 sold.

GAMMA Investing first reported a position in NGM in Q4 2023 and held it in 2 quarters. The position peaked at $550 in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • GAMMA Investing reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • GAMMA Investing sold 346 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $550.
  • GAMMA Investing first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • GAMMA Investing's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $550 in Q1 2024.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on GAMMA Investing's 13F filing for Q2 2024, filed 2 Jul 2024.